New stem cell autophagy surrogate diagnostic biomarkers in early-stage hepatocellular carcinoma in Egypt: A pilot study

doi:10.4254/wjh.v13.i12.2137

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 12

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2766)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-6) series.

Item

Count

PDF

184

WORD

HTML

1250

Figures (1-5)

155

Tables (1-6)

179

Sum=1844

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

333

Download

589

Sum=922

Dec 27, 2021 (publication date) through Apr 28, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Hepatol. Dec 27, 2021; 13(12): 2137-2149
Published online Dec 27, 2021. doi: 10.4254/wjh.v13.i12.2137

Table 3 Hepatitis virus B and C infections in the three study groups

Variable		HCC (n = 34), (%)	Chronic liver infection (n = 11), (%)	Control (n = 5), (%)	(X²)¹	P value
HCVAb	Positive	30 (88.2)	11 (100.0)	0 (0.0)	18.32 FE	< 0.001 HS
HCVAb	Negative	4 (11.8)	0 (0.0)	5 (100.0)	18.32 FE	< 0.001 HS
HBsAg	Positive	2 (5.9)	0 (0.0)	0 (0.0)	0.78 FE	1.00 NS
HBsAg	Negative	32 (94.1)	11 (100.0)	5 (100.0)	0.78 FE	1.00 NS

¹The chi-square test (FE: Fisher’s exact test). HBsAg: Hepatitis B virus surface antigen; HCC: Hepatocellular carcinoma; HCVAb: Hepatitis C virus antibody; HS: Highly significant; NS: Non-significant.

Citation: Yosef T, Ibrahim WA, Matboli M, Swilam AA, El-Nakeep S. New stem cell autophagy surrogate diagnostic biomarkers in early-stage hepatocellular carcinoma in Egypt: A pilot study . World J Hepatol 2021; 13(12): 2137-2149
URL: https://www.wjgnet.com/1948-5182/full/v13/i12/2137.htm
DOI: https://dx.doi.org/10.4254/wjh.v13.i12.2137